Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Agios Pharmaceuticals (AGIO) Receivables - Net (2016 - 2021)

Agios Pharmaceuticals (AGIO) has disclosed Receivables - Net for 7 consecutive years, with $4.4 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Receivables - Net changed N/A year-over-year to $4.4 million, compared with a TTM value of $4.4 million through Dec 2021, changed N/A, and an annual FY2021 reading of $4.4 million, changed N/A over the prior year.
  • Receivables - Net was $4.4 million for Q4 2021 at Agios Pharmaceuticals, up from $2.3 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $19.3 million in Q2 2018 and bottomed at $779000.0 in Q2 2017.
  • Average Receivables - Net over 5 years is $3.5 million, with a median of $2.5 million recorded in 2018.
  • The sharpest move saw Receivables - Net skyrocketed 2380.87% in 2018, then crashed 86.94% in 2019.
  • Year by year, Receivables - Net stood at $2.4 million in 2017, then rose by 0.57% to $2.5 million in 2018, then plummeted by 37.49% to $1.5 million in 2019, then skyrocketed by 51.66% to $2.3 million in 2020, then skyrocketed by 87.57% to $4.4 million in 2021.
  • Business Quant data shows Receivables - Net for AGIO at $4.4 million in Q4 2021, $2.3 million in Q3 2020, and $2.5 million in Q2 2020.